Inicio › Linfoma difuso de células B grandes › Illinois › Chicago
Ensayos clínicos de Linfoma difuso de células B grandes en Chicago, IL
18 estudios para Linfoma difuso de células B grandes buscan participantes en centros de Chicago y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma
ReclutandoFase 2
- Northwestern University, Chicago
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
ReclutandoFase 2
- University of Chicago Medical Center ( Site 0126), Chicago
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
ReclutandoFase 1
- The University of Chicago Medical Center (UCMC), Chicago
Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell Lymphoma
ReclutandoFase 1
- University of Chicago Comprehensive Cancer Center, Chicago
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
ReclutandoFase 2
- Northwestern University - Feinberg School of Medicine, Chicago
- Rush University Medical Center, Chicago
Study of Allo-QuadCAR01-T, an Allogeneic CAR-T Targeting CD19/CD20, in Patients With Relapsed or Refractory B-Cell Malignancies
ReclutandoFase 1/2
- University of Chicago, Chicago
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
ReclutandoFase 1/2
- University of Chicago Medical Center, Chicago
Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU
ReclutandoEstudio observacional
- Robert H Lurie Cancer Center, Chicago
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
ReclutandoFase 3
- Northwestern, Chicago
- University of Chicago, Chicago
DALY II USA/ MB-CART2019.1 for DLBCL
ReclutandoFase 2
- Robert H Lurie Cancer Center, Chicago
Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma
ReclutandoFase 1
- University of Illinois at Chicago, Chicago
Testing the Combination of Anti-cancer Drugs Mosunetuzumab, Polatuzumab Vedotin, and Lenalidomide for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma
ReclutandoFase 1
- Northwestern University, Chicago
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
ReclutandoFase 1
- Northwestern University, Chicago
The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
ReclutandoFase 1/2
- University of Illinois at Chicago Cancer Center, Chicago
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
ReclutandoFase 1
- The University of Chicago Medical Center, Chicago
Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
ReclutandoFase 2
- University of Illinois, Chicago
- University of Chicago Comprehensive Cancer Center, Chicago
Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment
ReclutandoFase 2
- University of Illinois, Chicago
- University of Chicago Comprehensive Cancer Center, Chicago
A Study of NX-1607 in Adults With Advanced Malignancies
ReclutandoFase 1
- University of Chicago, Chicago
Ensayos de Linfoma difuso de células B grandes en otras ciudades
- New York City, NY21 estudios
- Baldwin Park, CA19 estudios
- Houston, TX17 estudios
- Los Angeles, CA17 estudios
- Milwaukee, WI16 estudios
- Boston, MA16 estudios
- Philadelphia, PA15 estudios
- Portland, OR15 estudios
- Durham, NC14 estudios
- Nashville, TN14 estudios
- Dallas, TX13 estudios
- Seattle, WA12 estudios
Otros estudios en Chicago
- Cáncer de pulmón de células no pequeñas62 estudios
- Cáncer de seno58 estudios
- Cáncer (todos los tipos)53 estudios
- Cáncer metastásico45 estudios
- Cáncer de próstata45 estudios
- Obesidad42 estudios
- Cáncer de pulmón41 estudios
- Cáncer de ovario36 estudios
- Accidente cerebrovascular35 estudios
- Fallo cardíaco32 estudios
- Cáncer del colon y del recto32 estudios
- Sobrepeso28 estudios
De ClinicalTrials.gov, datos obtenidos el 30 sept 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.